Pancreatic cancer (2010)

John P. Neoptolemos, Raul Urrutia, James L. Abbruzzese, Markus W. Büchler (Eds.), Springer, 2010 (USA)

ISBN: 978-0-387-77499-2

Volume 1

Section 1. The nature of pancreatic cancer

1. Epidemiology and prospects for prevention of pancreatic cancer
2. Development and structure of the pancreas
3. Pathologic classification and biological behavior of pancreatic neoplasia
4. Developmental molecular biology of the pancreas
5. Molecular pathology of precursor lesions of pancreatic cancer
6. Epigenetics and its applications to a revised progression model of pancreatic cancer
7. Molecular pathology of pancreatic endocrine tumors
8. Sporadic pancreatic endocrine tumors
9. Molecular pathology of ampullary, intra-pancreatic bile duct and duodenal cancers
10. Miscellaneous non-pancreatic non-endocrine tumors
11. Molecular relationships between chronic pancreatitis and cancer
12. Pancreatic cancer stem cells
13. Cell cycle control in pancreatic cancer pathogenesis
14. Apoptosis signaling pathways in pancreatic cancer pathogenesis
15. EGFR signaling pathways in pancreatic cancer pathogenesis
16. Hedgehog signaling pathways in pancreatic cancer pathogenesis
17. Smad4/TGF-b signaling pathways in pancreatic cancer pathogenesis
18. Notch signaling in pancreatic morphogenesis and pancreatic cancer pathogenesis
19. Molecular characterization of pancreatic cancer cell lines
20. Mouse models of pancreatic exocrine cancer
21. Principles and applications of microarray gene expression in pancreatic cancer
22. Principles and applications of proteomics in pancreatic cancer
23. Tumor-stromal interactions in invasion and metastases
24. Genetic susceptibility and high risk groups for pancreatic cancer
25. Inherited pancreatic endocrine tumors

Volume 2

Section 2. Clinical management of pancreatic cancer

26. Clinical decision making in pancreatic cancer
27. Paraneoplastic syndromes in pancreatic cancer
28. Diagnostic and therapeutic response markers
29. CT and fusion PET-CT for diagnosis, staging and follow-up
30. MRI and MRCP for diagnosis and staging of pancreatic cancer
31. EUS for diagnosis and staging of pancreatic cancer
32. Laparoscopy and laparoscopic ultrasound for diagnosis and staging
33. Palliative management of pancreatic cancer
34. Diagnostic and therapeutic endoscopy in pancreatic cancer
35. Interventional radiology for pancreatic cancer
36. Palliative surgery in advanced pancreatic cancer
37. Chemotherapy for advanced pancreatic cancer
38. Developments in chemoradiation for advanced pancreatic cancer
39. Surgical resection for pancreatic cancer
40. Venous resection in pancreatic cancer surgery
41. Pathological reporting and staging following pancreatic cancer resection
42. Japanese pancreas society staging systems for pancreatic cancer
43. Adjuvant chemotherapy in pancreatic cancer
44. Adjuvant chemoradiation therapy for pancreatic cancer
45. Neoadjuvant treatment in pancreatic cancer
46. Borderline resectable pancreatic cancer
47. Management of cystic neoplasms of the pancreas
48. Laparoscopic surgery for pancreatic neoplasms
49. Modern japanese approach to pancreas cancer

Section 3. New directions

50. Development of novel pancreatic tumor biomarkers
51. Inherited genetics of pancreatic cancer and secondary screening
52. Gene therapy for pancreatic cancer
53. Vaccine therapy and immunotherapy for pancreatic cancer
54. Emerging therapeutic targets for pancreatic cancer